Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19842973 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study
Condition: HIV Infections
Interventions: Drug: Emtricitabine 200mg - Tenofovir 300mg;   Drug: Abacavir 600mg - Lamivudine 300mg

Study has passed its completion date and status has not been verified in more than two years.